Cue Health Inc.
HLTHQ · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $10 | $19 | $17 | $10 |
| % Growth | -46.5% | 7.6% | 76.6% | – |
| Cost of Goods Sold | $16 | $36 | $22 | $29 |
| Gross Profit | -$6 | -$17 | -$5 | -$19 |
| % Margin | -62.3% | -90.1% | -26.9% | -196.5% |
| R&D Expenses | $29 | $32 | $37 | $37 |
| G&A Expenses | $0 | $10 | $16 | $15 |
| SG&A Expenses | $8 | $16 | $23 | $23 |
| Sales & Mktg Exp. | $0 | $6 | $7 | $8 |
| Other Operating Expenses | $0 | $0 | -$21 | $0 |
| Operating Expenses | $38 | $48 | $39 | $59 |
| Operating Income | -$44 | -$65 | -$44 | -$79 |
| % Margin | -438% | -347.3% | -250.4% | -795.8% |
| Other Income/Exp. Net | -$5 | -$83 | $2 | -$5 |
| Pre-Tax Income | -$50 | -$148 | -$42 | -$84 |
| Tax Expense | $0 | $0 | $5 | $0 |
| Net Income | -$50 | -$148 | -$47 | -$84 |
| % Margin | -492.5% | -789.6% | -268.8% | -847.5% |
| EPS | -0.31 | -0.96 | -0.31 | -0.55 |
| % Growth | 67.7% | -209.7% | 43.6% | – |
| EPS Diluted | -0.31 | -0.96 | -0.31 | -0.55 |
| Weighted Avg Shares Out | 159 | 155 | 154 | 152 |
| Weighted Avg Shares Out Dil | 159 | 155 | 154 | 152 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$5 | $15 | $16 | $15 |
| EBITDA | -$49 | -$133 | -$26 | -$69 |
| % Margin | -491% | -706.5% | -147.5% | -696.2% |